Background illustration for clinical trials search

Paid Clinical Trials Meridian

Discover 216 paid clinical trials in Meridian, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin

for
Diabetes Mellitus, Type 2, Obesity
Location: Meridian ID, Spokane WA, West Jordan UT, Medford OR,

Sex: All

Age: 18 - 70+

Recruiting
FeaturedActive & Responsive

Flu and RSV Vaccine Studies for Adults 60+

for
Influenza, Human, Respiratory Syncytial Virus Infections
Location: Meridian ID, Seattle WA, San Bernardino CA, Peoria AZ,

Sex: All

Age: 60+

Recruiting
FeaturedActive & Responsive

Weight Loss Studies for Adults With a BMI of 27+, Including People Managing Type 2 Diabetes or Sleep Apnea

for
Obesity, Overweight, Diabetes Mellitus, Type 2,
Location: Meridian ID, Spokane WA, West Jordan UT, Medford OR,

Sex: All

Age: 18+

Recruiting
Featured

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

for
Migraine
Location: Meridian ID, Bountiful UT, Salt Lake City UT,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05125302

Phase 3, Recruiting
Featured

A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata

for
Severe Alopecia Areata
Location: Meridian ID, Los Angeles CA, El Paso TX, Omaha NE,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT07772492

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

for
Crohn's Disease
Location: Boise ID, Ogden UT, Tacoma WA, Seattle WA,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06548542

Phase 2, Recruiting
Featured

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

for
Crohn's Disease, Ulcerative Colitis
Location: Boise ID, Vancouver WA, Tacoma WA, Bellevue WA,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07697456

Phase 2, Recruiting
Featured

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Boise ID, Reno NV, Portland OR, Roseville CA, Kelowna,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06793215

Phase 3, Recruiting
Featured

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

for
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Location: Boise ID, Portland OR, Eugene OR, Tacoma WA, Clovis CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06806033

Phase 2, Recruiting
Active & Responsive

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Meridian ID, Boise ID, Nampa ID, Caldwell ID, Emmett ID,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05929768

Phase 3, Recruiting
Active & Responsive

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

for
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07018869

Phase 3, Recruiting
Active & Responsive

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

for
Ampulla of Vater Carcinoma, Appendix Carcinoma,
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07283939

Recruiting
Active & Responsive

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

for
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07091617

Recruiting
Active & Responsive

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

for
Diabetic Peripheral Neuropathic Pain
Location: Meridian ID, West Valley City UT, West Jordan UT,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT06628908

Phase 3, Recruiting
Active & Responsive

REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool

for
PTSD - Post Traumatic Stress Disorder
Location: Meridian ID, Aurora CO, Boston MA
Sponsor: Senseye, Inc.

Sex: All

Age: 18+

Code: NCT07280065

Phase 3, Recruiting
Active & Responsive

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

for
Atherosclerotic Cardiovascular Disease, Overweight, Obesity
Location: Meridian ID, Spokane WA, West Jordan UT, Provo UT,
Sponsor: Amgen

Sex: All

Age: 45 - 70+

Code: NCT07037433

Phase 3, Recruiting
Active & Responsive

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

for
Menstrual Migraine
Location: Meridian ID, Kelowna, Walnut Creek CA, Surrey,
Sponsor: Pfizer

Sex: Female

Age: 18 - 45

Code: NCT06641466

Phase 3, Recruiting
Active & Responsive

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

for
Obesity, Overweight
Location: Meridian ID, Layton UT, Bountiful UT, St. George UT,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07684235

Phase 3, Recruiting
Active & Responsive

A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease

for
Degenerative Disc Disease
Location: San Diego CA, Post Falls ID, Salt Lake City UT,
Sponsor: DiscGenics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07254806

Phase 3, Recruiting
Active & Responsive

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

for
Obesity or Overweight
Location: Meridian ID, Missoula MT, Redmond WA, Las Vegas NV,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07575399

Phase 3, Recruiting